- Home
- ALDX vs ELA Comparison
ALDX vs ELA Comparison
Compare ALDX & ELA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALDX
- ELA
- Stock Information
- Founded
- ALDX 2004
- ELA 1965
- Country
- ALDX United States
- ELA United States
- Employees
- ALDX N/A
- ELA N/A
- Industry
- ALDX Biotechnology: Pharmaceutical Preparations
- ELA Consumer Specialties
- Sector
- ALDX Health Care
- ELA Consumer Discretionary
- Exchange
- ALDX Nasdaq
- ELA Nasdaq
- Market Cap
- ALDX 133.7M
- ELA 156.2M
- IPO Year
- ALDX 2014
- ELA N/A
- Fundamental
- Price
- ALDX $2.15
- ELA $5.80
- Analyst Decision
- ALDX Strong Buy
- ELA Strong Buy
- Analyst Count
- ALDX 2
- ELA 1
- Target Price
- ALDX $9.50
- ELA $9.00
- AVG Volume (30 Days)
- ALDX 1.2M
- ELA 21.9K
- Earning Date
- ALDX 05-14-2025
- ELA 05-07-2025
- Dividend Yield
- ALDX N/A
- ELA N/A
- EPS Growth
- ALDX N/A
- ELA 15.15
- EPS
- ALDX N/A
- ELA 0.28
- Revenue
- ALDX N/A
- ELA $188,774,278.00
- Revenue This Year
- ALDX N/A
- ELA $7.61
- Revenue Next Year
- ALDX N/A
- ELA $6.27
- P/E Ratio
- ALDX N/A
- ELA $20.60
- Revenue Growth
- ALDX N/A
- ELA 14.19
- 52 Week Low
- ALDX $1.14
- ELA $4.20
- 52 Week High
- ALDX $7.20
- ELA $7.88
- Technical
- Relative Strength Index (RSI)
- ALDX 38.93
- ELA 37.93
- Support Level
- ALDX $2.15
- ELA $5.86
- Resistance Level
- ALDX $2.30
- ELA $6.81
- Average True Range (ATR)
- ALDX 0.15
- ELA 0.32
- MACD
- ALDX 0.06
- ELA -0.08
- Stochastic Oscillator
- ALDX 37.93
- ELA 0.00
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.
About ELA Envela Corporation
Envela Corp is a provider of recycling and re-commerce services at the forefront of the circular economy. These include re-commercializing luxury hard assets, consumer electronics and IT equipment; and end-of-life recycling solutions. It operates through two segments, Consumer, and Commercial Services. The Consumer segment which generates key revenue for the company predominantly buys to resell or recycle luxury hard assets like jewelry, diamonds, gemstones, fine watches, rare coins and related collectibles, precious-metal bullion products, gold, silver, and other precious metals. The Commercial Services segment provides asset-disposition solutions to government agencies, middle-market firms, corporations, and other organizations.